Abstract |
Cannabinoid system plays a pivotal role in the seizure threshold modulation which is mainly mediated through activation of the cannabinoid CB₁ receptor. There is also several evidence of interaction between cannabinoid system and α₂-adrenoceptors in different paradigms. Using model of clonic seizure induced by intravenous pentylenetetrazole (PTZ) in male mice, we investigated whether α₂-adrenoceptors is involved in the effects of cannabinoids on the seizure threshold. Injection of the selective cannabinoid CB₁ agonist ACEA (2 mg/kg) significantly (P<0.01) increased the seizure threshold which was prevented by pretreatment with the selective CB1 antagonist AM251 (1 mg/kg, i.p.). The highest doses of clonidine, a α₂ receptor agonist, (1 and 5 mg/kg) showed anticonvulsant effects while yohimbine, a α₂ receptor antagonist, (0.01, 0.1, 1, and 10 mg/kg) did not induce any significant effect on PTZ seizure threshold. Pretreatment with clonidine (0.1 and 0.5 mg/kg) significantly reversed the anticonvulsant effect of ACEA (2 mg/kg). Yohimbine (0.1, 1, and 10 mg/kg) pretreatment of mice enhanced the clonic seizure threshold of ACEA (1 mg/kg), significantly. Combination of non-effective doses of AM251 (0.1 mg/kg) and clonidine (0.01 mg/kg) showed additive effect in blocking the anticonvulsant effect of ACEA (2 mg/kg). In conclusion, our findings demonstrated that α₂-adrenoceptors could be involved in the anticonvulsant properties of the specific cannabinoid CB₁ agonist ACEA, suggesting that CB₁ cannabinoid and α₂ receptors have functional interactions in modulation of clonic seizure threshold.
|
Authors | Hamed Shafaroodi, Leila Moezi, Arsh Bahremand, Ahmad Reza Dehpour |
Journal | European journal of pharmacology
(Eur J Pharmacol)
Vol. 714
Issue 1-3
Pg. 1-6
(Aug 15 2013)
ISSN: 1879-0712 [Electronic] Netherlands |
PMID | 23756131
(Publication Type: Journal Article)
|
Copyright | Copyright © 2013 Elsevier B.V. All rights reserved. |
Chemical References |
- Anticonvulsants
- Arachidonic Acids
- Cannabinoids
- Piperidines
- Pyrazoles
- Receptor, Cannabinoid, CB1
- Receptors, Adrenergic, alpha-2
- arachidonyl-2-chloroethylamide
- Yohimbine
- AM 251
- Clonidine
- Pentylenetetrazole
|
Topics |
- Animals
- Anticonvulsants
(pharmacology)
- Arachidonic Acids
(pharmacology)
- Cannabinoids
(pharmacology)
- Clonidine
(pharmacology)
- Dose-Response Relationship, Drug
- Drug Interactions
- Male
- Mice
- Pentylenetetrazole
(adverse effects)
- Piperidines
(pharmacology)
- Pyrazoles
(pharmacology)
- Receptor, Cannabinoid, CB1
(agonists, antagonists & inhibitors)
- Receptors, Adrenergic, alpha-2
(metabolism)
- Seizures
(chemically induced, physiopathology)
- Yohimbine
(pharmacology)
|